Close

Corbus Pharma (CRBP) Receives EC Orphan Designation for Resunab as CF Treatment

October 18, 2016 7:05 AM EDT Send to a Friend
Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) announced that the European Commission has granted Orphan Designation in the European Union for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login